• About
  • Board
  • News
  • Sign Up
  • Contact

Visit

VJHemOnc
Logo
  • Home (current)
  • Diseases
    ALL
    AML
    CLL
    Lymphoma
    Multiple Myeloma
    Myeloproliferative Neoplasms
    View all Diseases
  • Topics
    Measurable Residual Disease
    CAR-T & Cellular Therapy
    Pharmacy
    Nursing
    Supportive Care
    Transplantation
    View all Topics
  • Conferences
    ASH
    2018
    UKONS
    2018
    ERIC
    2018
    BOPA
    2018
    ESH MM
    2018
    EORTC CLTF
    2018
    View all Conferences
  • Features
  • Podcasts
    • About
    • Board
    • News
    • Sign Up
    • Contact

combination therapy

2:45
Myeloma XI trial: increased progression-free survival
Charlotte Pawlyn
1:57
Pivotal STORM study: selinexor for penta-refractory multiple myeloma
Joshua Richter
1:04
Current challenges for multiple myeloma therapy: 2, 3, 4-drug combinations
Joshua Richter
04:20
Ibrutinib combinations for CLL: iLLUMINATE results & more
Carol Moreno
2:38
MPN updates: personalized prognostication, novel treatments & more
Ruben Mesa
1:53
Oral azacitidine plus R-CHOP for previously untreated NHL
John Leonard
1:05
Lessons in lymphoma: highlights in the field of NHL
John Leonard
2:25
Analyzing AML: novel therapies in review
Farhad Ravandi
1:33
PD-1 & PDL-1 combinations with CAR T-cell therapy
David Maloney
6:57
Key updates in MPNs from ASH 2018
Claire Harrison
1:06
Current hurdles in the treatment of CLL
Lindsey Roeker
0:55
CAR-T and ibrutinib in combination: a promising treatment for CLL
Lydia Scarfò
2:20
Investigating ibrutinib for CLL: IciCLLe & CLARITY
Peter Hillmen
4:01
CLL trial updates: ALLIANCE & iLLUMINATE
Barbara Eichhorst
2:36
iFCG for the frontline treatment of IGHV-mutated CLL: trial update
Nitin Jain
2:24
Better together? Ibrutinib and venetoclax for high-risk CLL
Nitin Jain
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 19
  • Next
VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

VJHO needs the contact information you provide to inform you about our latest hemonc news and videos, educational courses and industry supported content (some of which may be promotional in nature). You may unsubscribe from these communications at anytime. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy.

Please enter your details if you would like to receive the latest Hemonc news and updates

Continue
Video channels
  • Acute Lymphoblastic Leukemia
  • Acute Myeloid Leukemia
  • Acute Promyelocytic Leukemia
  • Amyloidosis
  • Anemia
  • Aplastic Anemia
  • B-Cell Lymphoma
  • Chronic Lymphocytic Leukemia
  • Chronic Myeloid Leukemia
  • CNS Lymphoma
Join our community

Keep up-to-date via social media

Sign up for email updates

Get great new content delivered to your inbox

Sign up

Magdalen Centre
The Oxford Science Park
Oxford OX4 4GA, United Kingdom

The content of VJHemOnc is intended for healthcare professionals
  • Cookie Policy
  • Privacy Policy
  • Terms of Use